INTRODUCTION: So far, hardly any experience exists whether end-of-life research on patients' attitudes towards hastened death in Germany is feasible and how it is perceived by the patients. MATERIALS AND METHODS: During the initial phase of a validation study of the German version of the Schedule of Attitudes towards Hastened Death, we documented reasons for non-inclusion. RESULTS AND DISCUSSION: Of 124 patients seen on the participating palliative care units, 18 (15%) were finally included in the study. Reasons for non-inclusion were mainly due to the clinical status of the patients; the German specific history of involuntary euthanasia during the Nazi regime did not prevent patients to participate. CONCLUSION: We conclude that end-of-life research in Germany is indeed feasible, however, faces difficulties similar to the international experience.
INTRODUCTION: So far, hardly any experience exists whether end-of-life research on patients' attitudes towards hastened death in Germany is feasible and how it is perceived by the patients. MATERIALS AND METHODS: During the initial phase of a validation study of the German version of the Schedule of Attitudes towards Hastened Death, we documented reasons for non-inclusion. RESULTS AND DISCUSSION: Of 124 patients seen on the participating palliative care units, 18 (15%) were finally included in the study. Reasons for non-inclusion were mainly due to the clinical status of the patients; the German specific history of involuntary euthanasia during the Nazi regime did not prevent patients to participate. CONCLUSION: We conclude that end-of-life research in Germany is indeed feasible, however, faces difficulties similar to the international experience.
Authors: Sydney Morss Dy; Lisa R Shugarman; Karl A Lorenz; Richard A Mularski; Joanne Lynn Journal: J Am Geriatr Soc Date: 2007-11-20 Impact factor: 5.562
Authors: B Rosenfeld; W Breitbart; M Galietta; M Kaim; J Funesti-Esch; H Pessin; C J Nelson; R Brescia Journal: Cancer Date: 2000-06-15 Impact factor: 6.860
Authors: W Breitbart; B Rosenfeld; H Pessin; M Kaim; J Funesti-Esch; M Galietta; C J Nelson; R Brescia Journal: JAMA Date: 2000-12-13 Impact factor: 56.272
Authors: Mogens Groenvold; Morten Aa Petersen; Neil K Aaronson; Juan I Arraras; Jane M Blazeby; Andrew Bottomley; Peter M Fayers; Alexander de Graeff; Eva Hammerlid; Stein Kaasa; Mirjam A G Sprangers; Jakob B Bjorner Journal: Eur J Cancer Date: 2005-09-12 Impact factor: 9.162
Authors: Keith G Wilson; Harvey Max Chochinov; Christine J McPherson; Merika Graham Skirko; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger; Andrea M Karam; Jennifer J Clinch Journal: Health Psychol Date: 2007-05 Impact factor: 4.267
Authors: Raymond Voltz; Maren Galushko; Johanna Walisko; Ute Karbach; Nicole Ernstmann; Holger Pfaff; Friedemann Nauck; Lukas Radbruch; Christoph Ostgathe Journal: Support Care Cancer Date: 2010-04-28 Impact factor: 3.603
Authors: Heidrun Golla; Maryam Ale Ahmad; Maren Galushko; Jürgen Hampl; Mohammad Maarouf; Michael Schroeter; Ulrich Herrlinger; Martin Hellmich; Raymond Voltz Journal: Support Care Cancer Date: 2014-08-19 Impact factor: 3.603